mAM Facilitates Conversion by ESET of Dimethyl to Trimethyl Lysine 9 of Histone H3 to Cause Transcriptional Repression by Wang, Hengbin et al.
Molecular Cell, Vol. 12, 475–487, August, 2003, Copyright 2003 by Cell Press
mAM Facilitates Conversion by ESET
of Dimethyl to Trimethyl Lysine 9 of Histone H3
to Cause Transcriptional Repression
erochromatin formation, transcriptional regulation, DNA
methylation, and X chromosome inactivation (Kouzar-
ides, 2002; Lachner and Jenuwein, 2002; Zhang and
Reinberg, 2001).
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(lysines 4, 9, 27, 36, and 79) and H4 (lysine 20) haveUniversity of North Carolina at Chapel Hill
been reported to be sites of methylation. Of the differentChapel Hill, North Carolina 27599
site-specific methylation events, lysine 9 methylation is2 Laboratory of Molecular Biology and Biochemistry
the best studied due to its fundamental role in hetero-Rockefeller University
chromatin formation, transcriptional silencing, X chro-New York, New York 10021
mosome inactivation, and DNA methylation (Richards3 Molecular Biology Program
and Elgin, 2002). Studies by Jenuwein and colleaguesMemorial Sloan Kettering Cancer Center
uncovered SUV39H1 and its fission yeast homolog Clr4New York, New York 10021
as the first H3-lysine 9 (H3-K9)-specific histone methyl-4 IGBMC, CNRS/INSERM
transferase (HMTase) (Rea et al., 2000). A link between67404 Illkirch, Strasbourg
H3-K9 methylation and transcriptional silencing was ini-France
tially established by analysis of the histone methylation
patterns at the fission yeast mating-type locus and the
chicken -globin locus, where H3-K9 methylation corre-Summary
lates with histone hypoacetylation and gene silencing
(Litt et al., 2001; Noma et al., 2001). Consistent withMethylation of histone tails plays an important role
this correlation, H3-K9 methylation was found to inhibitin chromatin structure and function. Previously, we
subsequent histone acetylation by p300 (Wang et al.,reported that ESET/SETDB1 is a histone methyltrans-
2001). However, a direct role of H3-K9 methylation inferase (HMTase). Here, we show that SETDB1 tightly
transcriptional repression has not been demonstrated.associates with the human homolog of mAM, a murine
In addition to Suv39h1 and its close relative Suv39h2ATFa-associated factor. Although recombinant ESET
(O’Carroll et al., 2000), at least three additional mamma-can methylate lysine 9 of histone H3 (H3-K9), its activity
lian proteins (G9a, ESET/SETDB1, and Eu-HMTase 1)is severely compromised when compared to that of
have been reported to possess H3-K9-specific HMTasethe ESET/mAM complex. mAM stimulates ESET enzy-
activity. Unlike the Suv39h proteins, which mainly func-matic activity by increasing the Vmax and decreasing the
tion in heterochromatin regions (Peters et al., 2001), G9aKm. Importantly, mAM facilitates the ESET-dependent
mainly methylates histone H3 in euchromatic regionsconversion of dimethyl H3-K9 to the trimethyl state
(Tachibana et al., 2001). Inactivation of G9a through tar-both in vitro and in vivo. Chromatin-based transcrip-
geted gene disruption in mice resulted in growth retarda-tion and ChIP analyses demonstrate that mAM en-
tion and early embryonic lethality (Tachibana et al.,hances ESET-mediated transcriptional repression in
2002), indicating that G9a-mediated H3-K9 methylationa SAM-dependent manner, and this repression corre-
of euchromatin is essential for early embryogenesis.lates with H3-K9 trimethylation at the promoter. Thus,
Similar to G9a, ESET/SETDB1 mainly methylates histoneour studies establish that promoter H3-K9 trimethyla-
H3 in euchromatic regions (Schultz et al., 2002). Eu-tion is the cause of transcriptional repression and that
HMTase 1, which also functions in euchromatin, associ-mAM/hAM facilitates conversion of H3-K9 dimethyl to
ates with E2F-6, Mga, and Max, and therefore is poten-
trimethyl by ESET/SETDB1.
tially involved in silencing of E2F- and Myc-responsive
genes in quiescent cells (Ogawa et al., 2002).
Introduction The fact that multiple HMTases target the same lysine
residue for methylation raises the question as to whether
Studies in the past two years have revealed that histone methylation on H3-K9 by different enzymes has similar
methylation plays an important role in modulating chro- consequences and how the enzymatic activities of the
matin structure and function (Lachner and Jenuwein, different HMTases are regulated to coordinate their
2002; Zhang and Reinberg, 2001). Histone methylation functions. The fact that disruption of G9a and Suv39h
occurs on arginine and lysine residues and is catalyzed in mice results in different phenotypes (Peters et al.,
by two distinct families of proteins, the PRMT1 family 2001; Tachibana et al., 2002) indicates that these pro-
and the SET domain-containing protein family (Zhang teins perform distinct functions. Because lysine can
and Reinberg, 2001). Recent studies have revealed a be mono-, di-, or trimethylated and because some
third family of HMTases that target lysine 79, located in HMTases, such as SET7/9 and Dim5, have been shown
the globular domain of histone H3 (Feng et al., 2002; Ng to methylate lysines to different states (Tamaru et al.,
et al., 2002; van Leeuwen et al., 2002). Accumulating 2003; Xiao et al., 2003), it is possible that different H3-
evidence indicates that histone methylation plays impor- K9 methyltransferases may methylate K9 to different
tant roles in multiple biological processes including het- states. Given that transcription is affected differentially
depending on the methylation state of H3-K4 (Santos-
Rosa et al., 2002), it is important to determine whether*Correspondence: yi_zhang@med.unc.edu
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the H3-K9 methyltransferases can methylate the same two protein bands, one of which was recognized by
the ESET antibody, copurify with the enzymatic activityresidue to different states.
Previously, we demonstrated that ESET is an H3-spe- (Figure 1C).
Extensive cofractionation through a variety of col-cific HMTase (Yang et al., 2002). To understand the func-
tion of ESET/SETDB1 and its associated HMTase activ- umns suggested that the two proteins were likely com-
ponents of a stable complex. To confirm this possibility,ity, we searched for an in vivo functional partner. Here,
we report the purification and characterization of a na- the partially purified SETDB1 complex was immunopre-
cipitated by the antibody that recognizes SETDB1. Thetive ESET/SETDB1 complex. We demonstrate that
SETDB1 tightly associates with the human homolog of 200 kDa protein coimmunoprecipitates with the 180 kDa
protein (Figure 1D, top panel). Western blot analysismAM, a murine ATFa-associated factor with transcrip-
tional repression activity. We found that mAM stimulates confirmed that the 180 kDa protein is SETDB1 (Figure
1D, bottom panel). The association of the 200 kDa pro-the HMTase activity of ESET through facilitating the con-
version by ESET from di- to trimethyl at H3-K9. Impor- tein with SETDB1 is specific, as none of the other pro-
teins present in the input coimmunoprecipitate withtantly, trimethylation of H3-K9 by the ESET complex
greatly impedes transcription from chromatin. Thus, our SETDB1 (Figure 1D, top panel). Given that the native
complex is larger than 670 kDa (Figure 1B) while the twostudies have uncovered mAM as the first molecule that
has the ability to modulate the activity of an HMTase, subunits are only about 400 kDa when added together, it
is likely that the two proteins exist as a hetero-multimer.and demonstrate directly that trimethylation of H3-K9
causes transcriptional repression. Having established that the 200 kDa protein exists in
a protein complex with SETDB1, we attempted to iden-
tify the protein by mass spectrometry. As expected, allResults
peptides obtained from the 180 kDa protein matched
SETDB1 (Figure 1E). Mass spectrometric analysis of thePurification and Identification
of a SETDB1-Containing HMTase Complex peptides derived from the 200 kDa protein revealed that
it best matches the 609-amino acid hypothetical proteinPreviously, we, as well as others, demonstrated that the
murine protein ESET and its human homolog SETDB1 FLJ10688 that was deposited into GenBank as part of
a human cDNA sequencing project. This putative partialpossess histone H3-specific methyltransferase activity
(Schultz et al., 2002; Yang et al., 2002). To gain insight protein sequence is highly similar to the C-terminal part
of the 1306 amino acid transcriptional repressor mAMinto the function of this HMTase, we raised an antibody
against the N terminus of ESET. This antibody recog- (mouse ATFa-associated Modulator) that was identified
in a yeast two-hybrid screen using ATFa as a bait (Denized one band around 180 kDa in nuclear extracts de-
rived from both HeLa cells and a murine cell line (Yang Graeve et al., 2000). Since the 609 amino acid putative
protein FLJ10688 is too small to account for the ob-et al., 2002), indicating that the antibody is specific and
can recognize endogenous SETDB1 in HeLa cells. To served 200 kDa mass and corresponds to the C terminus
of mAM, it likely represents the C terminus of the humanidentify functional partners for SETDB1, we fractionated
HeLa nuclear extracts by monitoring HMTase activity mAM counterpart. Analysis of multiple human EST
clones and human genome sequences resulted in clon-and SETDB1 protein. Using a six-column purification
scheme (Figure 1A), we purified a SETDB1-containing ing of a 4.1 kb cDNA with an open reading frame of 1270
amino acids (accession number AY337596) that is highlyHMTase complex. Fractionation of the partially purified
sample on a Superose 6 gel filtration column followed related to (78% identical) the mouse protein mAM
throughout the entire sequence (data not shown). Basedby silver staining and enzymatic assay revealed that the
enzymatic activity elutes between 670–2000 kDa and on its similarity to mAM, we have named the human
protein hAM.correlates with two protein bands of 200 kDa and 180
kDa, respectively (Figure 1B, top and middle panels).
The 180 kDa protein band, likely to be SETDB1, was mAM Stimulates the HMTase Activity of ESET
SETDB1 and its mouse homolog ESET have both beenrecognized by the ESET antibody (Figure 1B, bottom
panel). Further fractionation of the pooled Superose 6 shown to contain intrinsic HMTase activity (Schultz et
al., 2002; Yang et al., 2002). To assess the potential rolefractions on a Mono Q column confirmed that only the
Figure 1. Purification of a SETDB1 Histone Methyltransferase Complex
(A) Schematic representation of the steps used to purify the SETDB1 HMTase complex. Numbers represent salt concentrations (mM) at which
SETDB1 elutes from the columns.
(B) Silver staining of an SDS-polyacrylamide gel (top panel), HMTase activity assay (middle panel), and Western blotting analysis (bottom
panel) of the fractions derived from the Superose 6 gel filtration column. The elution profile of the protein markers is indicated on top of the
panel. SETDB1 is indicated by “*”, and the polypeptide that cofractionates with SETDB1 is indicated by “#.”
(C) Silver staining of an SDS-polyacrylamide gel (top panel), HMTase assay (middle panel), and Western blotting analysis (bottom panel) of
fractions derived from the Mono Q column. In and Ft represent input and flowthrough, respectively.
(D) Affinity purification of the SETDB1 complex. An aliquot of DEAE5PW input was immunoprecipitated with anti-ESET antibody crosslinked
to protein A agarose beads. Proteins that bound to the antibody (IP) were analyzed by silver staining (top panel) and Western blotting (lower
panel).
(E) Coomassie staining of a 6.5%–11% gradient SDS-polyacrylamide gel containing the purified SETDB1 HMTase complex. The identities of
the polypeptides were based on mass spectrometric analysis of the indicated protein bands. The peptides obtained from each of the two
proteins are listed on the right side of the gel. Numbers correspond to the amino acid number of the indicated protein.
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Figure 2. Reconstitution of the ESET/mAM
Complex
(A) Silver staining of an SDS-polyacrylamide
gel containing purified recombinant ESET,
mAM, and ESET/mAM complex.
(B) Comparison of the HMTase activities of
the native complex and that of recombinant
ESET. The amounts of enzymes used were
quantified by Western blotting (top panel).
Their corresponding activities toward equal
amounts of core histone substrates are
shown (bottom panel).
(C) Comparison of the HMTase activities of
the native complex and the reconstituted
ESET complex. The amounts of enzymes
used were quantified by Western blotting (top
panel). Their corresponding activities toward
equal amounts of core histone substrates are
shown (bottom panel).
of hAM/mAM in modulating the enzymatic activity of mAM stimulates the HMTase activity of ESET could be
due to either or both of the following possibilities: oneSETDB1/ESET, we expressed and purified Flag-tagged
is that mAM modulates the substrate specificity suchESET and HA-tagged mAM from baculovirus-infected
that the ESET/mAM complex methylates additional sitesSF9 cells either individually or in combination (Figure
other than that methylated by ESET. The second possi-2A). Although the recombinant ESET protein possesses
bility is that the ESET/mAM complex targets the samehistone H3 methyltransferase activity, its activity is com-
lysine residue on H3 for methylation but with an in-promised when compared with equal amounts of native
creased efficiency. To differentiate between these twocomplex (Figure 2B), raising the possibility that hAM/
possibilities, we first analyzed the effect of mAM on themAM may modulate the SETDB1/ESET enzymatic ac-
substrate specificity of ESET.tivity.
Equivalent amounts of histone H3, either in complexTo explore this possibility, recombinant HA-mAM was
with other core histones or in mono- or oligonucleosomeadded to the ESET HMTase assay. Surprisingly, instead
form, were subjected to methylation by equal amountsof stimulating the HMTase activity, the added mAM in-
of ESET alone or in a complex with mAM. While ESEThibited ESET HMTase activity (data not shown). One
and the ESET/mAM complex both can methylate H3 inexplanation for this unexpected result is that formation
core or mononucleosome forms, the enzymatic activityof a stable, functional ESET/mAM complex requires
of ESET/mAM complex is significantly higher (Figurecoexpression of the two proteins. Precedent for a similar
3A). Interestingly, the ESET/mAM complex also pos-situation was reported in reconstitution of NuRD histone
sesses modest activity toward oligonucleosomal H3,deacetylase activity, where stimulation of HDAC activity
which can be inhibited by the presence of histone H1by MTA2 was observed only when HDAC and MTA2
(Figure 3A, compare lanes 7 and 8).were coexpressed (Zhang et al., 1999). To explore this
Having established that free core histone H3 is a pre-possibility, we reconstituted the ESET/mAM complex by
ferred substrate, we attempted to determine the lysinecoinfection of SF9 cells with recombinant baculoviruses
residues targeted by ESET. Thus, recombinant histoneexpressing Flag-tagged ESET and HA-tagged mAM and
H3 was subjected to methylation by ESET in the pres-purified the ESET/mAM complex to homogeneity (Figure
ence of S-adenosyl-L-[methyl-3H]methionine (3H-SAM).2A, lane 3). Comparison of the reconstituted complex
Microsequencing of the methylated H3 followed by liq-with that of the native SETDB1 complex purified from
uid scintillation counting revealed that lysine 9 is theHeLa cells indicates that they possess comparable lev-
only residue methylated by ESET (Figure 3B). A similarels of HMTase activity (Figure 2C). These results collec-
result was obtained when the native SETDB1 complextively suggest that mAM has the ability to stimulate the
was used (data not shown). To confirm that lysine 9 isHMTase activity of ESET.
the only site methylated by this enzyme, histone H3
mutants were used as substrates. Results shown in Fig-
Both ESET and ESET/mAM Complex Specifically ure 3C indicate that while mutation of lysine 9 completely
Methylate H3-K9 eliminated the ability of H3 to serve as a substrate (lane
Given that multiple lysine residues on histone H3 are 3), mutation of any of the other potential methylation
susceptible to methylation (Lachner and Jenuwein, sites did not significantly affect the ability of H3 to serve
as a substrate regardless of whether ESET, the reconsti-2002; Zhang and Reinberg, 2001), the observation that
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Figure 3. Substrate and Site-Specificity of Recombinant ESET and ESET Complex
(A) ESET and ESET complex prefer nonnucleosomal histone H3 substrates. Left panel shows an ethidium bromide-stained agarose gel
containing core histones, mononulceosomes, and oligonulceosomes as indicated. Equal amounts of ESET, alone or in complex with mAM,
were used to methylate equal amounts of histones (bottom panel) in different contexts. The top panel is an autoradiograph of the bottom
panel. Quantification of two independent experiments is shown in the middle panel. Variations between the two experiments are indicated
by error bars.
(B) Lysine 9 of H3 is the major methylation site of SETDB1/ESET. Recombinant H3 that was methylated by the native complex was blotted
onto PVDF membrane and subjected to N-terminal automated sequencing. 3H-radioactivity eluted from each cycle was quantitated by
scintillation counting. The amino acids identified at each cycle of microsequencing are listed on the bottom.
(C) HMTase assays using recombinant H3 proteins with mutations at different lysine residues as substrates. The lysine residues that were
mutated are indicated on the top of the panel. Enzymes used in the assay are indicated on the left of the panel. Coomassie staining shows
that an equal amount of substrate was used in the assay.
tuted ESET/mAM complex, or the native SETDB1 com- min/ESET, respectively, while the Km and Vmax for ESET/
mAM complex are 1.27 M and 455 methyl groups/plex was used as the enzyme source. Thus, we conclude
that mAM does not alter the substrate specificity of min/complex, respectively. Based on these data, we
conclude that mAM stimulates the ESET HMTase activ-ESET.
ity by increasing the Vmax 2.7-fold and decreasing the Km
1.4-fold. Since Vmax measures the turnover number andmAM Stimulates the HMTase Activity of ESET
Km represents the dissociation constant of the enzyme-by Increasing Vmax and Decreasing Km
substrate complex, our results indicate that mAM stimu-To address the possibility that mAM stimulates the
lates the HMTase activity of ESET mainly through anHMTase activity of ESET by altering the reaction kinet-
increase in the turnover rate of the reaction.ics, we determined the reaction kinetics using recombi-
nant ESET and the ESET/mAM complex. A time course
of HMTase activity assays established that the reaction mAM Facilitates Conversion by ESET of H3-K9
from Di- to Trimethylis linear over 30 min (data not shown). Thus, all reactions
were performed for 15 min. By varying the SAM concen- Given that lysine methylation can exist in three different
states (mono-, di-, and trimethylated), we attempted totration, we determined the reaction velocities for both
recombinant ESET (Figure 4A) and ESET/mAM complex address whether the stimulation occurs at a particular
step. To this end, we compared the ability of ESET and(Figure 4B). The maximal velocity (Vmax) and the Michae-
lis-Menten constant (Km) were then determined by a dou- the ESET/mAM complex to methylate H3 peptides that
are either unmethylated or dimethylated at lysine 9. Atble-reciprocal plot. This analysis revealed that the Km
and Vmax for ESET are 1.78 M and 167 methyl groups/ the enzyme concentrations tested and using an unmeth-
Molecular Cell
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Figure 4. Kinetic Analysis of the HMTase Reactions Catalyzed by ESET and ESET Complex Using Core Histones as the Substrate
Representative autoradiographs are shown in the top panels, and quantification of two independent experiments is shown in the middle
panels. Double-reciprocal plots of the reactions catalyzed by ESET and ESET complex are shown in the bottom panels. Km and Vmax values
were derived from the double-reciprocal plots. (A) and (B) use ESET and ESET/mAM complex as enzyme, respectively.
ylated peptide substrate, the ESET/mAM complex is samples were divided into three parts for fluorogram
and Western blotting with antibodies that recognize di-about 2-fold more active than ESET alone (Figure 5A,
compare filled circles with filled squares). However, effi- or trimethyl H3-K9. Results shown in Figure 5D (bottom
two panels) indicate that ESET alone mainly methylatescient methylation of an H3-K9-dimethylated peptide by
ESET requires association with mAM (compare open H3-K9 to the dimethyl state, while the ESET/mAM com-
plex mainly methylates H3-K9 to the trimethyl state.circles with open squares). To ascertain that mAM
mainly affects the efficiency of ESET in converting di- Collectively, the above results allow us to conclude that
mAM facilitates the ability of ESET to convert H3-K9methyl to trimethyl, the data in Figure 5A are presented
in Figure 5B using an alternative method. The total incor- from the dimethyl to the trimethyl state in vitro.
To assess the in vivo relevance of the above finding,porated radioactivity for mono- and dimethylation of
the unmethylated peptide was derived by deducting the we asked whether the methylation state of the bulk H3-
K9 changes when SETDB1 and hAM are knocked downradioactivity observed with the dimethylated peptide
from that observed with the unmethylated peptide as a using the siRNA approach. Toward this end, an RNA
oligonucleotide corresponding to amino acids 803–808substrate. From this analysis, it is clear that while ESET
and the ESET/mAM complex have similar efficiencies in of SETDB1 was synthesized and transfected into both
293T and HeLa cells. As controls, parallel mock transfec-methylating H3-K9 to mono- and dimethyl states (Figure
5B, compare open and filled circles), they differ signifi- tions were also performed. To increase the knock-down
efficiency, a second transfection was performed 24 hrcantly in their abilities to convert the dimethyl H3-K9 to
trimethyl (compare open and filled squares). The ability after the initial transfection. Interestingly, transfection
of siRNA for SETDB1 resulted in cell death in both cellof mAM to facilitate conversion by ESET of H3-K9 from
dimethyl to trimethyl was also confirmed by a time lines (Figure 6A). To assess the effect of the transfection
on SETDB1 and H3-K9 methylation levels, the cells stillcourse study (Figure 5C, compare open with filled
squares). alive after 3 days of transfection were collected and
analyzed by Western blotting. Results shown in FigureTo further verify the above result, we extended the
peptide studies to recombinant H3. After methylation of 6B indicate that transfection of siRNA resulted in signifi-
cant reduction of SETDB1 in both cell lines while havingrecombinant H3 with amounts of ESET or ESET/mAM
complex that transferred equal numbers of methyl no effect on an unrelated protein SUZ12 (top two pan-
els). Consistent with the fact that SETDB1 is an H3-groups (Figure 5D, lanes 2 and 3 in second panel), the
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Figure 5. mAM Facilitates Conversion of Di- to Trimethyl Lysine at H3-K9 by ESET
(A) Comparison of the efficiencies of ESET and the ESET/mAM complex in methylating unmodified or dimethylated H3 peptides (aa 1–21).
Different concentrations of enzymes were incubated with peptide substrates (9 M) in the presence of 3H-SAM at 30C for 15 min. After
resolving the proteins on an SDS-polyacrylamide gel, the dried gel slices were quantified and plotted. A representative autoradiograph of an
SDS-polyacrylamide gel is presented in the insert.
(B) Comparison of the ability of ESET and ESET/mAM complex to methylate H3-K9 to different methylated states. Data presented were derived
from (A) (see text).
(C) A time course comparison of the efficiency of ESET and ESET/mAM complex to methylate H3-K9 to different methylated states. Reactions
were performed with an enzyme concentration of 2 pmol. Data were derived by methods similar to those used in (B).
(D) Equal amounts of HMTase activity of ESET alone or in a complex with mAM were used to methylate equal amounts of recombinant histone
H3 (top panel). The reactions were divided into three parts for autoradiography (second panel) and Western blotting (bottom two panels) using
antibodies specific for dimethylated and trimethylated lysine 9, respectively.
K9-specific HMTase, siRNA-mediated knock-down of transfection of two different constructs expressing
siRNAs for SETDB1 resulted in a significant reductionSETDB1 resulted in decreased levels of di- and tri-
methyl-K9 (Figure 6B and data not shown). in the SETDB1 level and concomitant decreases in the
levels of di- and trimethyl-K9 (Figure 6C). ConsistentTo further verify the above results, we attempted to
suppress SETDB1 expression using a modified DNA with the observation that the SETDB1 knock-down re-
sulted in cell death, further selection of the cells in thevector-based RNAi approach (Brummelkamp et al.,
2002; Sui et al., 2002). DNA constructs expressing presence of puromycin did not result in stable SETDB1
knock-down cell lines. Indeed, neither the SETDB1 levelsiRNAs that target two different regions of SETDB1 (aa
803–808 and 384–389) were transfected into HeLa and nor the H3-K9 methylation levels changed in cells trans-
fected with vectors expressing siRNAs for SETDB1 rela-293T cells in parallel with an empty vector. Transfected
cells were selected by culturing the cells in the presence tive to that of an empty vector after 3 weeks of puromy-
cin selection (data not shown). Our explanation is thatof puromycin. Six days after selection, the SETDB1 level
and H3-K9 methylation state were analyzed by Western cells expressing siRNA for SETDB1 die while the surviv-
ing cells only express the puromycin resistance gene.blotting. Consistent with the siRNA oligonucleotide-
mediated SETDB1 knock-down results (Figure 6B), To address whether hAM is capable of facilitating
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Figure 6. Knock-Down of SETDB1 and hAM by siRNA Affects H3-K9 Dimethyl and Trimethyl Levels
(A) Knock-down of SETDB1 results in cell death. Survival curves of 293T and HeLa cells after mock and SETDB1 siRNA transfections. Viable
cells were counted by trypan blue staining at different days after the second transfection (see Experimental Procedures).
(B) Western blot analysis of total cell lysates derived from mock and siRNA transfected cells (top panels). Equal amounts of histones extracted
from mock and siRNA transfected 293T cells were blotted with antibodies specific for di- or trimethylated H3-K9 (bottom panels). Antibodies
used are indicated on the left side of the panels.
(C) Western blot analysis of total cell lysates or histones derived from 293T cells transfected with empty vector or vectors expressing siRNAs
targeted to two regions of SETDB1 after 6 days of selection (top four panels). Equal loading of histone H3 was verified by Coomassie staining
of a parallel gel. The labeling is the same as that in (B).
(D) The same as that in (C) except that hAM was the target for knock-down by DNA vector-based siRNA.
H3-K9 trimethylation by SETDB1 in vivo, a similar DNA (Figure 6D). These results, in combination with the data
shown in Figure 5, allow us to conclude that mAM/hAMvector-based RNAi approach was used to knock-down
hAM. Results shown in Figure 6D indicate that knock- facilitates ESET/SETDB1-mediated methylation of H3-
K9 to the trimethyl state both in vitro and in vivo.downs of hAM with two siRNA-expressing vectors that
target different regions of hAM (aa 506–511 and 1037–
1042) each resulted in a significant reduction of the hAM mAM Enhances Transcriptional Repression by ESET
Concomitant with Promoter H3-K9 Trimethylationlevel concomitant with an increased level of dimethyl-
K9 and a decreased level of trimethyl-K9. However, the Having established that mAM/hAM facilitates conver-
sion by ESET/SETDB1 from dimethyl-H3-K9 to trimethyl-SETDB1 level was not affected by hAM knock-down
The ESET/SETDB Histone Methyltransferase Complex
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Figure 7. mAM Enhances ESET Transcriptional Repression by Facilitating Promoter-Specific Trimethylation on H3-K9
(A) Scheme of transcription and ChIP assays.
(B) Representative transcription and quantification results using chromatin and naked DNA templates. “” indicates the presence of a particular
factor in the reaction. For comparison of repression activity, equivalent amounts of ESET and ESET/mAM complex, based on the transfer of
equal numbers of methyl groups to H3-K9, were used in transcription reactions. Experiments were repeated three times with comparable
results. Similar results were also obtained when Gal4-p53 was replaced by Gal4-VP16.
(C) Representative results of ChIP analysis of the histone methylation status in promoter and distal regions. “” and “” indicate the presence
or absence of a particular factor. Antibodies used in the ChIP assay are indicated on the left of the panel. Experiments were repeated twice
with comparable results.
H3-K9, we attempted to address the functional con- (lanes 8–12). In the absence of the methyl donor SAM,
only a modest repression activity was observed for bothsequence of this conversion. Toward this end, recom-
binant ESET or ESET/mAM complex was used in a re- ESET and the ESET/mAM complex (Figure 7B, top two
panels, compare lanes 8 and 10 with 3). In the presenceconstituted chromatin transcription system in which
transcription activation (here by Gal4-p53) is dependent of SAM, however, a much more pronounced level of
repression (up to 20-fold for the ESET/mAM complex)upon p300 and acetyl-CoA (An et al., 2002). As dia-
grammed in Figure 7A, chromatin assembly, remodeling, was achieved (compare lanes 9 and 11 with 3). No signifi-
cant differences in transcription were detected in paral-and activator binding were achieved before addition of
the histone-modifying enzymes p300 and either ESET lel experiments using a naked DNA template (Figure 7B,
bottom two panels). Similar results were also obtainedor the ESET/mAM complex. After histone modification,
nuclear extract was added to allow preinitiation complex when Gal4-p53 was replaced by Gal4-VP16 (data not
shown). The SAM-dependent effect strongly suggestsformation, and transcription was initiated by NTP addi-
tion. Similar to previous results (An et al., 2002), Gal4- that the repression activity is dependent on the HMTase
activity of ESET or the ESET/mAM complex. Moreover,p53-activated transcription was stimulated by p300 and
acetyl-CoA (Figure 7B, top two panels, lanes 1–3). Since the observation that mAM enhances ESET repression
activity, which requires the presence of SAM, stronglythe low level of transcription in the absence of coactiva-
tor p300 precluded a clear demonstration of the repres- argues that H3-K9 trimethylation is the cause of the
repression.sion activity of ESET or the ESET/mAM complex (lanes
4–7), the effect of ESET and the ESET/mAM complex The SAM-dependent transcriptional repression by
ESET or the ESET/mAM complex in the above chroma-on transcription was analyzed in the presence of p300
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tin-based transcriptional assay appears contrary to the vivo (Figures 5 and 6). This capability is linked to its
capacity to enhance transcriptional repression by ESETdemonstration that neither ESET nor ESET/mAM has
significant HMTase activity toward oligonucleosomal on a chromatin template (Figure 7).
In addition to modulating the enzymatic activity ofhistone substrate (Figure 3A). However, it is possible
that chromatin remodeling by ACF (present in the tran- ESET and enhancing its transcriptional repression activ-
ity, mAM is also likely to bridge interactions of ESETscription assay) coupled with binding of activators may
open up the promoter region and allow nucleosomal with certain transcription factors. mAM was initially iden-
tified in a yeast two-hybrid screen using ATFa, a memberhistone methylation by ESET and ESET/mAM complex.
To test this possibility, the methylation state of H3-K9 of the CREB/ATF family of transcription factors, as a
bait (De Graeve et al., 2000). mAM has been reported toin the promoter region and in a distal region 2 kb down-
stream were analyzed by chromatin immunoprecipita- possess a weak ATPase activity. Although this ATPase
activity may potentially contribute to the ability of thetion (ChIP) assays. These results clearly demonstrate
oligonucleosomal H3-K9 methylation both by ESET and ESET/mAM complex to methylate nucleosomal his-
tones, its exact function is currently unknown. Protein-by the ESET/mAM complex (Figure 7C). In addition,
ESET activity is restricted to dimethylation whereas the protein interaction studies indicate that mAM is able to
interact with components of the basal transcription ma-ESET/mAM complex activity results primarily in trimeth-
ylation (compare lanes 2 and 6). Importantly, methylation chinery including TFIIE, TFIIH, and RNAPII (De Graeve
et al., 2000), raising the possibility that this might con-is largely restricted to the promoter region and is com-
pletely dependent upon the presence of the activator. tribute to its repression activity. However, the SAM-
dependent enhancement of transcriptional repressionParallel ChIP assays using a dimethyl-H3-K4 antibody
demonstrate that H3-K4 is not methylated, verifying the and promoter-specific trimethylation on H3-K9 strongly
argue that histone methylation is a major cause of thespecificity of both the enzyme and the ChIP assay. Col-
lectively, the above results confirm that ESET and ESET/ observed transcriptional repression (Figure 7). Whether
ESET/mAM can also methylate components of the basalmAM complex are capable of methylating nucleosomal
histone at H3-K9 and that the consequence of this modi- transcription machinery remains to be determined. Thus
far, at least three transcription factors or corepressorsfication is transcriptional repression. Moreover, the
mAM-enhanced transcriptional repression by ESET is that belong to distinct protein families have been dem-
onstrated to be capable of interacting with ESET/dependent on its ability to facilitate conversion from di-
to trimethyl at H3-K9. SETDB1 or mAM. These proteins include the ETS family
member ERG (Yang et al., 2002), the KRAB-ZFP core-
pressor KAP-1 (Schultz et al., 2002), and the CREB/ATFDiscussion
family member ATFa (De Graeve et al., 2000). These
observations suggest that the ESET/mAM complex isESET/SETDB1 Functions as a Heteromultimer
likely to be involved in the regulation of a variety ofand Can Be Targeted to Euchromatic Regions
genes targeted by the different transcription factors.by Multiple Transcription Factors
This is consistent with the fact that SETDB1/ESET isESET was initially identified in a yeast two-hybrid screen
widely distributed throughout the nucleus (Schultz etaimed at identifying functional partners for the ETS fam-
al., 2002). Given the existence of at least four HMTasesily of transcription factor ERG (Yang et al., 2002). The
that methylate H3-K9, it will be important to determinepresence of evolutionarily conserved SET, preSET, and
how the different HMTases with the same site specificitypostSET domains implicated in histone methylation (Rea
are targeted to different genes to perform their func-et al., 2000) in ESET prompted us to test for an intrinsic
tions.HMTase activity. As a result, we demonstrated that ESET
specifically methylates histone H3 (Yang et al., 2002).
Independent studies using the KRAB-ZFP corepressor Transcriptional Repression by H3-K9 Methylation
Is Dependent on the Methylation StateKAP-1 as a bait identified the human homolog of ESET,
named SETDB1, as an H3-K9 methyltransferase (Schultz Histone methylation plays an important role in transcrip-
tional regulation (Kouzarides, 2002; Zhang and Rein-et al., 2002). Importantly, SETDB1 colocalizes with the
heterochromatin protein HP1 in nonpericentromeric eu- berg, 2001). Unlike histone acetylation, which generally
correlates with gene activation (Roth et al., 2001), thechromatin regions and both proteins are recruited to an
integrated reporter containing KRAB binding sites, thus consequence of histone methylation appears to be site
dependent. For example, H3-K4 methylation correlatessuggesting that SETDB1 plays an important role in eu-
chromatic gene silencing (Schultz et al., 2002). In this with transcriptional activation while H3-K9 methylation
correlates with transcriptional repression (Litt et al.,study, we demonstrate that ESET/SETDB1 associates
with mAM/hAM in vivo and that the two proteins likely 2001; Noma et al., 2001). However, recent studies indi-
cate that the effects of histone lysine methylation onfunction as a heteromultimer as judged by the sizes of
the native human complex (Figure 1B) and the reconsti- transcription are likely to be even more complicated.
Studies in budding yeast, using antibodies that discrimi-tuted mouse complex (data not shown). Comparison of
the enzymatic activities of the recombinant ESET and nate between the di- and trimethylated states, indicate
that while dimethylation of H3-K4 can occur at boththe ESET/mAM complex revealed that association of
mAM with ESET has functional consequences. mAM inactive and active euchromatic genes, trimethyl-H3-K4
is present exclusively at active genes (Santos-Rosa etstimulates ESET enzymatic activity, and this effect re-
quires incorporation of the two proteins into one protein al., 2002). This observation indicates that the conse-
quences of histone methylation for gene expression arecomplex (Figure 2). Significantly, mAM facilitates ESET
to convert di- to trimethyl at H3-K9 both in vitro and in not only site dependent, but also are methylation state
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485
Supplemental Data (http://www.molecule.org/cgi/content/full/12/2/dependent. Consistent with this notion, we and others
475/DC1). Recombinant ESET, mAM, and ESET/mAM complex werehave recently demonstrated that H3-K27 trimethylation
expressed in SF9 cells. Purification was achieved using a combina-but not dimethylation is involved in X inactivation (Plath
tion of ion exchange, gel filtration, and affinity columns. A detailed
et al., 2003; Silva et al., 2003). Using a chromatin-based description of the purification process is available in the Supplemen-
transcriptional system coupled with ChIP assays, we tal Data.
have now demonstrated that methylation on H3-K9 is
the cause of transcriptional repression. Consistent with HMTase Assay, Western Blotting, Protein Identification,
this notion, targeting of an HMTase-deficient SUV39H1 and Methylation Site Determination
Histone methylation and Western blot analyses were performed asmutant is less efficient in transcriptional repression than
previously described (Wang et al., 2001). Substrates used for thethat of its wild-type counterpart (Snowden et al., 2002).
HMTase assays included histone octamer, mononucleosomes, andSignificantly, we demonstrate that promoter H3-K9 tri-
oligonucleosomes that were purified as described (Fang et al., 2002).methylation results in much more potent transcriptional Protein identification and methylation site determination were also
repression than promoter H3-K9 dimethylation. Thus, performed as previously described (Wang et al., 2001). Wild-type
methylation state-dependent “read out” appears to be and mutant recombinant histone H3 were purified as previously
described (Cao et al., 2002). Peptides and the H3-K9 dimethyl-spe-a general phenomenon.
cific antibodies were purchased from Upstate Biotechnology (USA).Why do cells need different HMTases to methylate
ESET and trimethyl-specific H3-K9 antibodies were previously de-H3-K9? One explanation is that different enzymes are
scribed (Yang et al., 2002). Antibodies against mAM were producedtargeted to different chromosomal domains and/or in rabbits using the first 320 amino acids as antigen.
genes. Alternatively, different enzymes may have differ-
ent preferences toward non-, mono-, and dimethylated
Kinetic Analysis of the HMTase Reactions
substrates. Previous studies using recombinant SUV39H1 Methylation reactions were performed with different concentrations
indicate that dimethylated H3 peptide is a poor sub- of 3H-SAM. The reactions were allowed to proceed for 15 min and
strate, suggesting that SUV39H1 alone may not be able were terminated by the addition of SDS sample buffer. Histones
were separated by 18% SDS-PAGE, and gel pieces containing his-to trimethylate histone H3 (Rea et al., 2000). Whether
tone H3 were excised and quantified by scintillation counting. ASUV39H1 is capable of trimethylating H3 when it associ-
histone sample with a known amount of radioactivity (cpm) was runates with its in vivo functional partner remains to be
at the same time to calibrate the methyl group incorporation into
determined. Our preliminary analysis of G9a null ES cells histones.
indicates that while the loss of G9a greatly affects the
bulk H3-K9 dimethylation level, the trimethlation level
Cell Viability and Knock-Down Assays
does not appear to be affected (data not shown), indicat- HeLa and 293T cells were cultured in DMEM media supplied with
ing that G9a may not be able to trimethylate H3-K9. 10% FBS. siRNA, with the sequence of 5-AAGUUCGGCUACAGCU
Given the sequence and structural similarities between AUUCA-3 (Dharmacon), was transfected into cells using Oligofec-
tamine (Invitrogen) following the manufacturer’s instruction. TheEu-HMTase 1 and G9a, Eu-HMTase 1 is unlikely to cata-
transfection was repeated 24 hr after the initial transfection. Celllyze H3-K9 trimethylation. Since most, if not all, ESET
viability was determined by trypan blue staining. Three days afteris tightly associated with mAM in vivo, it is likely that a
transfection, cells were harvested and total cell extracts and his-
major function of ESET is to trimethylate H3-K9. Whether tones were prepared for Western blotting as previously described
it is the only enzyme that catalyzes H3-K9 trimethylation (Wang et al., 2001). For DNA vector-based knock-down, the desired
remains to be determined. The identification of mAM/ 19 bp stem-loop RNAs were expressed from the pHTPsiRNA vector
(a gift from Bill Reed at UNC-Chapel Hill) driven by the human H1hAM as an ESET/SETDB1 functional partner and the
gene promoter. The vector also contains an SV40 promoter thatdemonstration that mAM enhances the ability of ESET
drives transcription of a puromycin N-acetyl-transferase gene con-to repress transcription through trimethylation on H3-
ferring puromycin resistance. Vectors expressing the following hair-
K9 provide direct evidence that H3-K9 trimethylation is pin RNAs were transfected into HeLa and 293T cells by Effectene
the cause of transcriptional repression. (Invitrogen). Transfected cells were selected with 2 g/ml (HeLa) or
It worth noting that while some mammalian HMTases 4 g/ml (293T) puromycin for 6–7 days before analysis. The two
siRNAs that target SETDB1 are: 5-GTTCGGCTACAGCTATTCATTsuch as SET7/Set9 (Nishioka et al., 2002a; Wang et al.,
CAAGAGATGAATAGCTGTAGCCGAAC-3 and 5-ATGTGAGTGGAT2001) and SET8/PR-Set7 (Fang et al., 2002; Nishioka et
CTATCGTTCAAGAGACGATAGATCCACTCACATC-3. The two siRNAal., 2002b) were purified as single subunit enzymes, a
that target hAM are: 5-CATCTCTCCTTCCAATCGATTCAAGAGAT
few others such as EZH2 (Cao et al., 2002; Kuzmichev CGATTGGAAGGAGAGATG-3 and 5-ATCACACTCCTGTATCAACT
et al., 2002), its Drosophila counterpart E(Z) (Czermin et TCAAGAGAGTTGATACAGGAGTGTGAT-3 (targeted sequences
al., 2002; Muller et al., 2002), and ESET have been found are underlined).
to function as protein complexes in vivo. The other sub-
units in these enzyme complexes likely modulate the Transcription and ChIP Assays
The steps involved in transcription and ChIP assays are outlined inenzymatic activity or substrate specificity. They also
Figure 7A. For in vitro transcription, chromatin template (40 ng) waslikely play important roles in targeting the HMTases to
preincubated with Gal4-p53 (20 ng) and histone-modifying factorsspecific genes by mediating interactions between the
(10 ng p300, 30 ng ESET, 20 ng ESET/mAM complex) prior to theenzymes and specific transcription factors. The chal-
sequential addition of nuclear extract (for preinitiation complex for-
lenge for us in the future is to identify specific genes mation) and the four ribonucleoside 5-triphosphates (for initiation
targeted by the various enzymes or enzyme complexes. of transcription) as described (An et al., 2002). In vitro ChIP assays
were performed essentially as described (An et al., 2002), except
that DNA sequences in the immunoprecipitates were monitored byExperimental Procedures
PCR amplification using primers that flank the promoter (5 primer,
5-CTCGGATCCAGCGAGCTCGAGTGC-3; 3 primer, 5-AGTGAGPurification of the Native SETDB1 Complex, Recombinant ESET,
mAM, and ESET/mAM Complex GACGAACGCGCCCCCACC-3) or primers for a distal region located
2 kb downstream from the promoter (5 primer, 5-GACGCTCAGTGPurification of the native SETDB1 complex is outlined in Figure 1A.
A detailed description of the purification process is available in the GAACGAAAACTCA-3; 3 primer, 5-GGAGGCGGATAAAGTTGCA
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GGACC-3). PCR analysis with identical primers on input chromatin tail modifications required for heterochromatin formation. Genes
Dev. 16, 479–489.confirmed that equal chromatin amounts were used for all reactions.
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